Search - tctmd.com

Displaying 341 - 360 of 504

Sort: Relevancy | Date

News Daily News

Los Descensos Importantes de la Presión Arterial parecen Reducir de Forma Segura el Riesgo de ACV en Pacientes EAC

Todd Neale

November 02, 2014

News Daily News

PARTNER Data Provide More Evidence of Mortality Impact of Post-TAVR Regurgitation

October 10, 2014

News Daily News

Datos del PARTNER ofrecen Más Evidencias del Impacto de la Mortalidad sobre la Regurgitación Post-TAVR

October 10, 2014

News Daily News

IABP Therapy May Benefit Patients With Large STEMI, Persistent Ischemia Post-PCI

Caitlin E. Cox

October 03, 2014

News Daily News

El Tratamiento con IAMP Podría Beneficiar a Pacientes con STEMI Grandes e Isquemia Persistente Post-PCI

Caitlin E. Cox

October 03, 2014

News Conference News TCT 2014

Symplicity Flex: No Benefit of Renal Denervation in Mild Resistant Hypertension

September 16, 2014

News Industry News

Randomized Sham-Controlled Trial Examines Blood Pressure Effects of Renal Denervation in Patients with Mild Refractory Hypertension

September 16, 2014

News Conference News TCT 2014

SYMPLICITY HTN-3 Substudy Examines BP Response Factors in African Americans

Yael L. Maxwell

September 15, 2014

News Industry News

Twelve-Month Data from St. Jude Medical EnligHTN Renal Denervation System Show Continued Safety and Efficacy for Patients

September 13, 2014

News Conference News TCT 2014

SYMPLICITY HTN-3: Crossover Patients Strengthen the Case for Renal Denervation

September 13, 2014

News Daily News

Incomplete Revascularization Linked to Poorer Outcomes in TAVR Patients With CAD

September 11, 2014

News Daily News

La Revascularización Incompleta se asocia a Peores Resultados en Pacientes TAVR con EAC

September 11, 2014

News Conference News ESC 2014

SYMPLICITY HTN-3: Renal Denervation Still Safe, Not Effective at 1 Year

Todd Neale

September 01, 2014

News Conference News ESC 2014

NOMI: Nitric Oxide May Do Wonders for STEMI But Not When Mixed with Nitroglycerin

Caitlin E. Cox

September 01, 2014

News Daily News

MitraClip Benefits High-, Prohibitive-Risk Patients with Mitral Regurgitation

July 10, 2014

News Daily News

MitraClip Beneficia a Pacientes de Riesgo Alto y Prohibitivo con Regurgitacion Mitral

July 10, 2014

News Daily News

SYMPLICITY HTN-2: Renal Denervation Safe, Effective at 3 Years

Yael L. Maxwell

June 11, 2014

News Daily News

SYMPLICITY HTN-2: La Denervación Renal es Segura y Eficaz a los 3 Años

Yael L. Maxwell

June 11, 2014

News Industry News

FDA Approves First Implantable Wireless Device with Remote Monitoring to Measure Pulmonary Artery Pressure in Certain Heart Failure Patients

May 28, 2014

News Industry News

Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

May 22, 2014

Advertisement

Los Descensos Importantes de la Presión Arterial parecen Reducir de Forma Segura el Riesgo de ACV en Pacientes EAC

PARTNER Data Provide More Evidence of Mortality Impact of Post-TAVR Regurgitation

Datos del PARTNER ofrecen Más Evidencias del Impacto de la Mortalidad sobre la Regurgitación Post-TAVR

IABP Therapy May Benefit Patients With Large STEMI, Persistent Ischemia Post-PCI

El Tratamiento con IAMP Podría Beneficiar a Pacientes con STEMI Grandes e Isquemia Persistente Post-PCI

Symplicity Flex: No Benefit of Renal Denervation in Mild Resistant Hypertension

Randomized Sham-Controlled Trial Examines Blood Pressure Effects of Renal Denervation in Patients with Mild Refractory Hypertension

SYMPLICITY HTN-3 Substudy Examines BP Response Factors in African Americans

Twelve-Month Data from St. Jude Medical EnligHTN Renal Denervation System Show Continued Safety and Efficacy for Patients

SYMPLICITY HTN-3: Crossover Patients Strengthen the Case for Renal Denervation

Incomplete Revascularization Linked to Poorer Outcomes in TAVR Patients With CAD

La Revascularización Incompleta se asocia a Peores Resultados en Pacientes TAVR con EAC

SYMPLICITY HTN-3: Renal Denervation Still Safe, Not Effective at 1 Year

NOMI: Nitric Oxide May Do Wonders for STEMI But Not When Mixed with Nitroglycerin

MitraClip Benefits High-, Prohibitive-Risk Patients with Mitral Regurgitation

MitraClip Beneficia a Pacientes de Riesgo Alto y Prohibitivo con Regurgitacion Mitral

SYMPLICITY HTN-2: Renal Denervation Safe, Effective at 3 Years

SYMPLICITY HTN-2: La Denervación Renal es Segura y Eficaz a los 3 Años

FDA Approves First Implantable Wireless Device with Remote Monitoring to Measure Pulmonary Artery Pressure in Certain Heart Failure Patients

Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content